An initial batch of million doses of a 13-valent pneumonia conjugate vaccination produced by China’s Walvax was sent to Morocco on May 21 from Yunnan Province in southwest China.
The vaccination is used to fight 13 frequent illnesses caused by the streptococcus pneumonia bacterium in children aged six weeks to six years.
In 2019, China created a 13-valent pneumonia vaccination independently. Previously, the sole accessible vaccination was produced by the American pharmaceutical company Pfizer.
The vaccine has been included in Morocco’s expanded immunization program to protect children from potentially fatal diseases.
According to the latest WHO data published in 2020 Influenza and Pneumonia Deaths in Morocco reached 7,237 or 3.17% of total deaths. The Death Rate is 22.11 per 100,000 the population ranking Morocco 106 in the world.
add your comment
Terms of publication : Not to offend the writer, people, sacred things, or attack religions or the divine self, and refrain from racist incitement and insults.